Targeted Genetics Corp., a Seattle-based biotechnology company, announced this week that it plans to begin human tests of an HIV vaccine later this year, the Seattle Post-Intelligencer reports. The company has already tested the vaccine, called tgAAC09, in rabbits and reported that the compound produced an immune system response to invading virus in the animals. Targeted Genetics earlier this year laid off a sizeable portion of its staff and cut several research programs to focus on the development of the HIV vaccine and potential treatments for cystic fibrosis and arthritis.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved














Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes
These are some of his worst comments about LGBTQ+ people made by Charlie Kirk.